Literature DB >> 9854026

The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways.

K Gonda1, H Okamoto, N Takuwa, Y Yatomi, H Okazaki, T Sakurai, S Kimura, R Sillard, K Harii, Y Takuwa.   

Abstract

In the present study, we determined the agonist specificity and the signalling mechanisms of a putative sphingosine 1-phosphate (S1P) receptor, AGR16. In CHO cells transiently transfected with an AGR16 expression vector, but not in cells transfected with an empty vector, the addition of a low concentration of S1P (1 nM) caused an increase in the intracellular free Ca2+ concentration ([Ca2+]i) by mobilization of Ca2+ from both intra- and extra-cellular pools. To determine the spectrum of agonists for AGR16, we employed K562 cells, which in the naive state do not respond at all to either S1P or structurally related lipids with an increase in [Ca2+]i. In K562 cells stably expressing AGR16, S1P and sphingosylphosphorylcholine (SPC) dose-dependently increased [Ca2+]i with half-maximal values of 3 nM and 100 nM respectively. In CHO cells stably expressing AGR16 (CHO-AGR16), but not in parental CHO cells, we observed specific binding of [32P]S1P, which was displaced by unlabelled S1P and SPC. In CHO-AGR16 cells, but not in parental CHO cells, S1P stimulated the production of inositol phosphates and Ca2+ mobilization which was only 30% inhibited by pertussis toxin (PTX), different from the case of the recently identified S1P receptor EDG1. Also in CHO-AGR16 cells, but not in CHO cells, S1P at higher concentrations activated mitogen-activated protein kinase (MAPK) in a PTX-sensitive and Ras-dependent manner. S1P also induced the activation of two stress-activated MAPKs, c-Jun N-terminal kinase and p38, in a manner that was totally insensitive to PTX. In CHO-AGR16 cells, S1P induced stress-fibre formation, with an increase in myosin light chain phosphorylation, in a PTX-insensitive and Rho-dependent manner. S1P also induced an increase in the cellular cAMP content in CHO-AGR16 cells, which contrasts sharply with the case of EDG1. These results establish that the S1P receptor AGR16 is coupled via both PTX-sensitive and -insensitive G-proteins to multiple effector pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9854026      PMCID: PMC1219937     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  56 in total

1.  Activation of p38 mitogen-activated protein kinase by signaling through G protein-coupled receptors. Involvement of Gbetagamma and Galphaq/11 subunits.

Authors:  J Yamauchi; M Nagao; Y Kaziro; H Itoh
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

2.  Thrombin activates two stress-activated protein kinases, c-Jun N-terminal kinase and p38, in HepG2 cells.

Authors:  H Mitsui; T Maruyama; S Kimura; Y Takuwa
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

3.  Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts.

Authors:  N Takuwa; Y Takuwa
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1.

Authors:  G C Zondag; F R Postma; I V Etten; I Verlaan; W H Moolenaar
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

5.  Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1.

Authors:  M J Lee; J R Van Brocklyn; S Thangada; C H Liu; A R Hand; R Menzeleev; S Spiegel; T Hla
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

6.  Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum.

Authors:  Y Yatomi; Y Igarashi; L Yang; N Hisano; R Qi; N Asazuma; K Satoh; Y Ozaki; S Kume
Journal:  J Biochem       Date:  1997-05       Impact factor: 3.387

7.  Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids.

Authors:  S An; T Bleu; W Huang; O G Hallmark; S R Coughlin; E J Goetzl
Journal:  FEBS Lett       Date:  1997-11-17       Impact factor: 4.124

8.  Stretch activates Jun N-terminal kinase/stress-activated protein kinase in vascular smooth muscle cells through mechanisms involving autocrine ATP stimulation of purinoceptors.

Authors:  K Hamada; N Takuwa; K Yokoyama; Y Takuwa
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

Review 9.  Molecular diversity of sphingolipid signalling.

Authors:  D Meyer zu Heringdorf; C J van Koppen; K H Jakobs
Journal:  FEBS Lett       Date:  1997-06-23       Impact factor: 4.124

10.  Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid.

Authors:  S An; T Bleu; O G Hallmark; E J Goetzl
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

View more
  39 in total

1.  Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.

Authors:  H Okamoto; N Takuwa; T Yokomizo; N Sugimoto; S Sakurada; H Shigematsu; Y Takuwa
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 2.  International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.

Authors:  Jerold Chun; Timothy Hla; Kevin R Lynch; Sarah Spiegel; Wouter H Moolenaar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  S1P₂ receptor regulation of sphingosine-1-phosphate effects on conventional outflow physiology.

Authors:  Grant M Sumida; W Daniel Stamer
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

Review 4.  Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease.

Authors:  S-K Jo; A Bajwa; A S Awad; K R Lynch; M D Okusa
Journal:  Kidney Int       Date:  2008-03-05       Impact factor: 10.612

5.  Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway.

Authors:  Lily I Jiang; Julie Collins; Richard Davis; Keng-Mean Lin; Dianne DeCamp; Tamara Roach; Robert Hsueh; Robert A Rebres; Elliott M Ross; Ronald Taussig; Iain Fraser; Paul C Sternweis
Journal:  J Biol Chem       Date:  2007-02-05       Impact factor: 5.157

Review 6.  Regulation of vascular physiology and pathology by the S1P2 receptor subtype.

Authors:  Athanasia Skoura; Timothy Hla
Journal:  Cardiovasc Res       Date:  2009-03-15       Impact factor: 10.787

7.  Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function.

Authors:  Enkhzol Malchinkhuu; Koichi Sato; Takeshi Muraki; Koichi Ishikawa; Atsushi Kuwabara; Fumikazu Okajima
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

8.  Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde.

Authors:  Noriko Takuwa; Wa Du; Erika Kaneko; Yasuo Okamoto; Kazuaki Yoshioka; Yoh Takuwa
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

9.  Sphingosine-1-phosphate inhibits nuclear factor kappaB activation and germ cell apoptosis in the human testis independently of its receptors.

Authors:  Laura Suomalainen; Virve Pentikäinen; Leo Dunkel
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

10.  Protein kinase C-epsilon regulates sphingosine 1-phosphate-mediated migration of human lung endothelial cells through activation of phospholipase D2, protein kinase C-zeta, and Rac1.

Authors:  Irina Gorshkova; Donghong He; Evgeny Berdyshev; Peter Usatuyk; Michael Burns; Satish Kalari; Yutong Zhao; Srikanth Pendyala; Joe G N Garcia; Nigel J Pyne; David N Brindley; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2008-02-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.